On October 21, 2024, the Company appointed Mr. Henry Du, age 46, to act as the Company's Vice President of Finance and Accounting and interim Chief Financial Officer effective October 21, 2024.
The Nxu Board also appointed Sarah Wyant (together with the Executives, the “Nxu Executives”), Nxu’s Interim Chief Financial Officer, to serve as Nxu’s Chief Financial Officer, effective on October 23, 2024.
On October 23, 2024, Fay Sien Goon, the Chief Financial Officer of the Company (who also serves as the Company’s principal financial officer and principal accounting officer), notified the Company’s Board of Directors (the “Board”) of her plans to depart the Company as of October 25, 2024 (the “Separation Date”).
the Board, on October 23, 2024, appointed Tim Eaton as the Company’ interim Chief Financial Officer (and principal financial officer) effective as of the Separation Date.
Departed
Dato' Seow Gim Shen
Chief Executive Officer and Chairman of the Board
TITAN PHARMACEUTICALS INC
Effective
2024-10-24
Filed
October 24, 2024, 7:59 PM ET
On October 24, 2024, Dato’ Seow Gim Shen notified the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) of his decision to resign as Chief Executive Officer and Chairman of the Board of the Company.
On October 24, 2024, the Board of Directors (the “Board”) of Advent Technologies Holdings, Inc. (the “Company”) approved the termination of the employment of Vassilios Gregoriou, the Chief Executive Officer, Acting Chief Financial Officer, for cause, effective immediately.
the Company’s board of directors appointed Mr. Gary Herman, who is currently serving as the Company’s Class I Director, to the additional role of interim chief executive officer, effective immediately
Appointed
(interim)
Albert Joon Lee
Interim Chief Executive Officer
Getaround, Inc
Effective
2024-10-15
Filed
October 23, 2024, 7:59 PM ET
On October 15, 2024, the Board appointed Albert Joon (“AJ”) Lee, the Company’s current Chief Operating Officer, as the Company’s Interim Chief Executive Officer, effective as of such date.
Departed
Eduardo Iniguez
Chief Executive Officer
Getaround, Inc
Effective
2024-10-15
Successor
Albert Joon Lee
Filed
October 23, 2024, 7:59 PM ET
On October 15, 2024, Eduardo Iniguez, the Chief Executive Officer of Getaround, Inc. (the “Company”), resigned from his position as Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of such date.
On October 21, 2024, Mr. Ken Tsang tendered his resignation as a Chief Financial Officer of Next Technology Holding Inc. (the “Company”), effective October 21, 2024.
On October 21, 2024, approved by the Board of Directors, Ms. Eve Chan was appointed as the Chief Financial Officer of the Company, effective October 21, 2024.
On October 23, 2024, the Company announced that Jason Dubinsky, chief financial officer, will be stepping down from his role with the company effective December 31, 2024, after which he will serve in a consulting capacity through June 30, 2025.
David Rosenberg, currently the Company’s Vice President – Investor Relations, has been appointed Executive Vice President and Chief Financial Officer to succeed Mr. Connor, effective March 1, 2025.
Departed
Frank T. Connor
Executive Vice President and Chief Financial Officer
On October 17, 2024, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Robert Eno as Chief Executive Officer of the Company (the “CEO Appointment”) effective as of October 21, 2024.
Sriram Ryali ceased to serve as the Company’s Chief Financial Officer and principal financial and accounting officer effective as of September 30, 2024.
Departed
Patrice H. Launay
Chief Financial Officer
ShiftPixy, Inc.
Effective
2024-10-18
Filed
October 22, 2024, 7:59 PM ET
On October 18, 2024, Patrice H. Launay resigned immediately as Chief Financial Officer of ShiftPixy, Inc. (the “Company”).
Departed
Scott W. Absher
Chief Executive Officer, Chairman of the Board, and President
ShiftPixy, Inc.
Effective
2024-10-19
Filed
October 22, 2024, 7:59 PM ET
On October 19, 2024, the Board of Directors of the Company (the “Board”) voted to terminate the employment of Scott W. Absher as the Company’s Chief Executive Officer, Chairman of the Board, and President, as being in the best interests of the Company and the Company’s shareholders resulting from the Board’s initial investigation into allegations involving actions of Mr. Absher.
Departed
Howard M. Lorber
Chairman of the Board and Chief Executive Officer and President
On October 21, 2024, Howard M. Lorber notified the Board of Directors (the “ Board ”) of Douglas Elliman Inc. (the “ Company ”) of his resignation as Chairman of the Board and Chief Executive Officer and President of the Company, effective immediately.
On October 22, 2024, the Board appointed Michael Liebowitz, an existing director of the Company, as the Company’s Chief Executive Officer (and principal executive officer) and Chairman of the Board, effective immediately, to fill the vacancies created by Mr. Lorber’s resignation.
David W. Barry, the current President of Pursuit, to serve as the Company’s President and Chief Executive Officer, contingent upon and effective as of the closing of the Transaction.
Steven W. Moster, President and Chief Executive Officer of the Company, who will step down from his role at the Company, contingent upon and effective as of the closing of the Transaction.
On October 17, 2024, the Board of Directors (the “Board”) of LPL Financial Holdings Inc. (the “Company”) appointed Rich Steinmeier, 50, as the Company’s Chief Executive Officer
Mark DiSiena, Chief Financial Officer ("CFO") of the Company, informed the Company that he intends to resign from his role at the Company, to be effective November 15, 2024
On October 14, 2024, Microvast Holdings, Inc. (the “Company”) entered into an employment offer letter with Fariyal Khanbabi pursuant to which Ms. Khanbabi will serve as the Company’s Chief Financial Officer (the “Offer Letter”).
Departed
Sergey Yeskov
President and Chief Executive Officer of the Company's EMEA&APAC business
announced that Sergey Yeskov, the President and Chief Executive Officer of the Company's EMEA&APAC business, resigned from the Company for personal reasons, effective October 17, 2024.
Departed
Steve Dang
Vice President of Finance and principal financial officer
Vado Corp.
Effective
2024-09-27
Successor
Amanda Edris
Filed
October 18, 2024, 7:59 PM ET
On September 27, 2024, Steve Dang, the Vice President of Finance and principal financial officer of Vado Corp. (the “Company”), resigned as the Vice President of Finance and principal financial officer.
Appointed
Amanda Edris
principal financial officer
Vado Corp.
Effective
2024-10-16
Filed
October 18, 2024, 7:59 PM ET
On October 16, 2024, the Company’s Board of Directors appointed Amanda Edris, 35, as the principal financial officer and as an executive officer of the Company
the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.
On October 17, 2024, Sunny Bhandarkar, the CEO and a director of Mobile Global Esports, Inc. (the “Company”) resigned as CEO and a director for personal reasons.
Role change
B. John Lindeman
Chief Executive Officer and Principal Executive Officer
B. John Lindeman will assume the role of Chief Executive Officer and Principal Executive Officer and no longer serve in his current position as Executive Vice President & Chief Financial Officer.
On October 16, 2024, the Board of Directors (the “Board”) of Energous Corporation d/b/a Energous Wireless Power Solutions (the “Company”) appointed Mallorie Burak as the permanent Chief Executive Officer of the Company and as a member of the Board, each effective immediately.
Departed
Kimi Iguchi
Chief Financial Officer and Treasurer
Sage Therapeutics, Inc.
Effective
2024-10-31
Successor
Chris Benecchi
Filed
October 17, 2024, 7:59 PM ET
the Board also approved the separation of Kimi Iguchi, its Chief Financial Officer and Treasurer, and Anne Marie Cook, its Senior Vice President, General Counsel, and Secretary, in each case effective October 31, 2024.
Role change
Robert Connelly
Principal Accounting Officer and Principal Financial Officer
On October 15, 2024 , Elicio Therapeutics, Inc. (the “Company”) appointed Robert Connelly as the Company’s Principal Accounting Officer and Principal Financial Officer effective October 15, 2024.
On October 11, 2024, the Board of Directors of Innovative Eyewear Inc. (the “Company”) appointed Oswald Gayle as the Company’s Co-Chief Financial Officer, effective immediately.
Appointed
(interim)
Richard Altice
Interim Chief Executive Officer
Danimer Scientific, Inc.
Effective
2024-10-15
Filed
October 16, 2024, 7:59 PM ET
Richard Altice, a current director of the Company has been named Interim Chief Executive Officer (“Interim CEO”) of the Company.
Departed
Stephen Croskrey
Chief Executive Officer
Danimer Scientific, Inc.
Effective
2024-10-14
Filed
October 16, 2024, 7:59 PM ET
Stephen Croskrey, who previously announced his intention to retire by the end of 2024 after more than eight years as Chief Executive Officer (“CEO”) of the Company, will no longer serve as CEO of the Company.
Departed
Eduardo Iniguez
Chief Executive Officer
Getaround, Inc
Effective
2024-10-15
Successor
Albert Joon Lee
Filed
October 16, 2024, 7:59 PM ET
On October 15, 2024, Eduardo Iniguez, the Chief Executive Officer of Getaround, Inc. (the “Company”), resigned from his position as Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of such date.
Appointed
(interim)
Albert Joon Lee
Interim Chief Executive Officer
Getaround, Inc
Effective
2024-10-15
Filed
October 16, 2024, 7:59 PM ET
On October 15, 2024, the Board appointed Albert Joon (“AJ”) Lee, the Company’s current Chief Operating Officer, as the Company’s Interim Chief Executive Officer, effective as of such date.
On October 10, 2024, the Board of Directors ("the Board") accepted the resignation from Mr. Stephen Kok Koon Tan as the Company's Chief Executive Officer and a director of the Company, as previously submitted on October 8, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.